Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/1/26 18:22 | 6/29/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Thomasian Harry Jr. | MD | O | CFO | 3 | S.dm | -1,296 | 3.93 | 0 | -329 | 596 | D | |||||||||||||||
7/1/26 18:21 | 6/29/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Shah Rutul R | MD | O | COO | 4 | M.d | 537 | 2.46 | 0 | 219 | 68 | 540 | D | ||||||||||||||
7/1/26 18:21 | 6/29/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Shah Rutul R | MD | O | COO | 4 | S.d | -537 | 2.46 | 0 | -219 | 540 | D | |||||||||||||||
7/1/26 18:19 | 6/29/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | O | P,CEO | 4 | M.d | 3,371 | 3.17 | 0 | 1,063 | 38 | 3,888 | D | ||||||||||||||
7/1/26 18:19 | 6/29/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | O | P,CEO | 4 | S.d | -3,371 | 3.17 | 0 | -1,063 | 3,888 | D | |||||||||||||||
6/1/26 16:28 | 5/28/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Tennant Phil | MD | O | Chief Co | 2 | S.d | -132 | 1.42 | 0 | -93 | 170 | D | |||||||||||||||
6/1/26 16:26 | 5/28/26 | PGEN | Health | Drug | Pharmaceutical Preparations | Lehr Donald P. | MD | O | GC | 2 | S.d | -127 | 1.39 | 0 | -92 | 785 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |